ODM-204 a novel dual inhibitor of CYP17A1 and androgen receptor: Early results from phase I dose escalation in men with castration-resistant prostate cancer

K Fizazi; RH Jones; C Massard; E Vjaters; KJ Peltola; P Nykanen

doi:10.1200/JCO.2017.35.6_suppl.246

ODM-204 a novel dual inhibitor of CYP17A1 and androgen receptor: Early results from phase I dose escalation in men with castration-resistant prostate cancer

K Fizazi, RH Jones, C Massard, E Vjaters, KJ Peltola, P Nykanen

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	246
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	35
Issue number	6 Suppl.
DOIs	https://doi.org/10.1200/JCO.2017.35.6_suppl.246
Publication status	Published - 20 Feb 2017
Externally published	Yes
Event	2017 Genitourinary Cancers Symposium - Orlando, United States Duration: 16 Feb 2017 → 18 Feb 2017 https://ascopost.com/Meetings/?m=2017+Genitourinary+Cancers+Symposium

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2017.35.6_suppl.246

https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.6_suppl.246

Cite this

@article{cb97e09c926949c291bca53c0bc41602,

title = "ODM-204 a novel dual inhibitor of CYP17A1 and androgen receptor: Early results from phase I dose escalation in men with castration-resistant prostate cancer",

author = "K Fizazi and RH Jones and C Massard and E Vjaters and KJ Peltola and P Nykanen",

year = "2017",

month = feb,

day = "20",

doi = "10.1200/JCO.2017.35.6_suppl.246",

language = "English",

volume = "35",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "6 Suppl.",

note = "2017 Genitourinary Cancers Symposium, ASCO GU ; Conference date: 16-02-2017 Through 18-02-2017",

url = "https://ascopost.com/Meetings/?m=2017+Genitourinary+Cancers+Symposium",

}

TY - JOUR

T1 - ODM-204 a novel dual inhibitor of CYP17A1 and androgen receptor

T2 - 2017 Genitourinary Cancers Symposium

AU - Fizazi, K

AU - Jones, RH

AU - Massard, C

AU - Vjaters, E

AU - Peltola, KJ

AU - Nykanen, P

PY - 2017/2/20

Y1 - 2017/2/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:000443269500308&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1200/JCO.2017.35.6_suppl.246

DO - 10.1200/JCO.2017.35.6_suppl.246

M3 - Meeting Abstract

SN - 0732-183X

VL - 35

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 6 Suppl.

M1 - 246

Y2 - 16 February 2017 through 18 February 2017

ER -

ODM-204 a novel dual inhibitor of CYP17A1 and androgen receptor: Early results from phase I dose escalation in men with castration-resistant prostate cancer

Field of Science*

Publication Type*

UN SDGs

Access to Document

Other files and links

Cite this